Baixia Yang
Overview
Explore the profile of Baixia Yang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
258
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shen S, Lyu P, Yang B, Yang X, Li Y, Zhu Z, et al.
Int J Radiat Biol
. 2023 Feb;
99(9):1343-1351.
PMID: 36731456
Objective: Radiation-induced heart disease (RIHD) is one of the most common and serious long-term adverse effect after thoracic radiotherapy. Our aim was to investigate the potential molecular mechanism underlying RIHD...
2.
Wang Z, Yang B, Zhan P, Wang L, Wan B
J Cancer Res Ther
. 2023 Jan;
18(7):1910-1918.
PMID: 36647949
The controversy over the efficacy of postoperative radiotherapy (PORT) has existed for a long time. The present study reassessed the overall survival (OS) and disease-free survival (DFS) data to investigate...
3.
Chen S, Shi Y, Lu Z, Wang M, Cong L, Yang B, et al.
Cancer Control
. 2021 May;
28:10732748211004886.
PMID: 33998308
Objective: Esophageal carcinosarcoma (ECS) is a rare malignant tumor that accounts for only 0.5%-2.8% of all esophageal malignancies. As most current studies are case reports, the relationship between clinical features...
4.
Zhu J, Liang X, Wu D, Chen S, Yang B, Mao W, et al.
Medicine (Baltimore)
. 2021 Apr;
100(15):e25237.
PMID: 33847621
Objective: This study aimed to investigate the clinicopathological features and the survival outcomes of neuroendocrine prostate cancer (NEPC). Methods: Within the Surveillance, Epidemiology, and End Results (SEER) database of the...
5.
Kan C, Yang J, Na D, Xu Y, Yang B, Zhao H, et al.
Bone Res
. 2019 Nov;
7:33.
PMID: 31700694
Heterotopic ossification (HO), true bone formation in soft tissue, is closely associated with abnormal injury/immune responses. We hypothesized that a key underlying mechanism of HO might be injury-induced dysregulation of...
6.
Zhu J, Chen S, Yang B, Mao W, Yang X, Cai J
Biosci Rep
. 2019 Aug;
39(8).
PMID: 31391206
Radiotherapy is one of the main modalities of cancer treatment. However, tumor recurrence following radiotherapy occurs in many cancer patients. A key to solving this problem is the optimization of...
7.
Tan C, Qian X, Ge Y, Yang B, Wang F, Guan Z, et al.
Pathol Oncol Res
. 2016 Sep;
23(2):323-328.
PMID: 27585443
To evaluate the radiosensitization of Oroxylin A on esophageal carcinoma cell as well as the optimal scheduling of Oroxylin A and radiotherapy (RT). Cell proliferation was estimated by a CCK8...
8.
Qian X, Tan C, Wang F, Yang B, Ge Y, Guan Z, et al.
Onco Targets Ther
. 2016 May;
9:2247-54.
PMID: 27143920
Esophageal carcinoma (EC) is a lethal disease with high morbidity and mortality worldwide, and the incidence has been increasing in recent years. Although the diagnosis and treatment of EC have...
9.
Tan C, Qian X, Guan Z, Yang B, Ge Y, Wang F, et al.
Springerplus
. 2016 Apr;
5:467.
PMID: 27119071
Esophageal cancer, which consist of esophageal adenocarcinoma and esophageal squamous cell carcinoma, is one of the most common malignant tumors in the world, especially in the south of Iran and...
10.
Ge X, Yang X, Lu X, Wen W, Zhen F, Ye H, et al.
Tumori
. 2015 Mar;
101(2):168-73.
PMID: 25791535
Purpose: This study evaluated the effectiveness and safety of intensity-modulated radiation therapy (IMRT) for locally advanced esophageal squamous cell carcinoma (ESCC). Methods: Between August 2009 and December 2011, 112 patients...